retatrutide fda approval status 2025 Trial of next-gen weight-loss drug brings it one step closer to Demand for Unapproved Weight-Loss Drug

Monitoring liver function is standard practice in the clinical trials and would be expected in any future approved protocol

Our experienced research team in Denver Every clinical trial is overseen by a Principal Investigator a physician who is responsible for the rights, safety and welfare of the study participants

Please note that there are temporary shipping restrictions for this product in the states of Alabama, Arkansas, District of Columbia , Louisiana, Massachusetts, Mississippi, Oklahoma, South Carolina, Washington

Serious Risks and Safety Monitoring As with other medicines affecting GLP-1 pathways, researchers are monitoring potential risks such as pancreatitis and gallbladder-related conditions

Medicare (new for 2026) Starting July 1, 2026, the Centers for Medicare and Medicaid Services opened a temporary Medicare GLP-1 Bridge program offering a capped monthly copay for qualifying Medicare Part D beneficiaries, running through December 31, 2027

Prillaman M